Citius Pharmaceuticals Inc vs Prudential PLC — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Prudential PLC trades at $27.85 (market cap $34.02B). The key difference: Prudential PLC is far larger — about 1700.1× Citius Pharmaceuticals Inc's market cap, and Prudential PLC pays a 1.94% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | PUK | |
|---|---|---|
Market Cap | $20.01M | $34.02B |
Sector | Health | Financials |
52-Week High | $1.82 | $33.61 |
52-Week Low | $0.48 | $24.98 |
Enterprise Value | $16.23M | $35.46B |
Dividend Yield | — | 1.94% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →